More on PHVS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.0 Score)

Upcoming Events

- Earnings (7/27/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Pharvaris (NQ:PHVS)
Delayed: 25.91 +0.07 (0.27%)
Prev. Close $25.84  
Open$25.50 
52 Wk High$ 
52 Wk Low$ 
Day High$26.33 
Day Low$25.04 
P/E N/A  
EPS$ 
Volume177,793 

Friends, Peers and Foes (?): RCKT (more...)

Mar 2, 2026 06:55 AM Pharvaris presents deucrictibant data at allergy conference
Mar 2, 2026 06:50 AM Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026
Feb 17, 2026 04:31 PM Form SCHEDULE 13G/A Pharvaris N.V. Filed by: Bain Capital Life Sciences Fund, L.P.
Feb 10, 2026 06:50 AM Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting
Jan 22, 2026 06:42 AM H.C. Wainwright Reiterates Buy Rating on Pharvaris B.V. (PHVS)
Jan 12, 2026 06:51 AM Form 6-K Pharvaris N.V. For: Jan 12
Jan 12, 2026 06:50 AM Pharvaris expects pivotal HAE study data in third quarter 2026
Jan 12, 2026 06:50 AM Pharvaris Outlines 2026 Strategic Priorities
Jan 2, 2026 04:30 PM Form 144 Pharvaris N.V. Filed by: Lu Peng
Dec 4, 2025 06:09 PM Form 144 Pharvaris N.V. Filed by: Abele Stefan Andreas
View All Articles

Entities mentioned with PHVS

View All Entities